Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Characterization of the Pathogenesis of Lymphangioleiomyomatosis (LAM)

NCT00001465 is registered in ClinicalTrials.gov with National Heart, Lung, and Blood Institute (NHLBI) as lead sponsor.

NCT NCT00001465
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00001465 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Characterization of the Pathogenesis of Lymphangioleiomyomatosis (LAM)
Lead sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Phase
Observational
Overall status
Recruiting
Start date
December 18, 1995
Completion date
Not reported
Enrollment
2,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lung disease, lymphangioleiomyomatosis, pneumothorax, tuberous sclerosis